586
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Healthcare costs associated with nephrology care in pre-dialysis chronic kidney disease patients

, , , , &
Pages 673-680 | Accepted 30 Sep 2010, Published online: 04 Nov 2010

References

  • U.S. Renal Data System. USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2009. Available at: http://www.usrds.org/adr_2009.htm. Accessed June 30, 2010
  • Khan S, Amedia CA Jr. Economic burden of chronic kidney disease. J Eval Clin Pract 2008;14:422-434
  • Trivedi H. Cost implication of caring for chronic kidney disease: are interventions cost-effective? Adv Chronic Dis 2010;17:265-270
  • National Kidney Foundation. Kidney Disease Outcomes Quality Initiative (KDOQI) Clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 2002;39(Suppl 1):S1-S66
  • Khan SS, Xue JL, Kazmi WH, et al. Does predialysis nephrology care influence patient survival after initiation of dialysis? Kidney Int 2005;67:1038-1046
  • Jungers P. Late referral: loss of chance for patient, loss of money for society. Nephrol Dial Transplant 2002;17:371-375
  • Roubicek C, Brunet P, Huiart L, et al. Timing of nephrology referral: influence on mortality and morbidity. Am J Kidney Dis 2000;36:35-41
  • Lorenzo V, Martin M, Rufino M, et al. Predialysis nephrologic care and a functioning arteriovenous fistula at entry are associated with better survival in incident hemodialysis patients: an observational cohort study. Am J Kidney Dis 2004;43:999-1007
  • Dogan E, Erkoc R, Sayarlioglu H, et al. Effects of late referral to a nephrologist in patients with chronic renal failure. Nephrology (Carlton) 2005;10:516-519
  • Schmidt RJ, Domico JR, Sorkin MI, et al. Early referral and its impact on emergent first dialysis, healthcare costs, and outcome. Am J Kidney Dis 1998;32:278-283
  • Goransson LG and Bergrem H. Consequences of late referral of patients with end-stage renal disease. J Intern Med 2001;250:154-159
  • Stoves J, Bartlett CN, Newstead CG, et al. Specialist follow up of patients before end stage renal failure and its relationship to survival on dialysis. Postgrad Med J 2001;77:586-588
  • Boulware LE, Troll MU, Jaar BG, et al. Nephrology referral of patients with progressive CKD: a national study. Am J Kidney Dis 2006;48:192-204
  • Levey AS, Coresh J, Balk E, et al. National Kidney Foundation: National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003;139:137-147
  • National Kidney Foundation. Kidney Disease Outcomes Quality Initiative (KDOQI), Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease, 2007 Update of Hemoglobin Target. Available at: http://www.kidney.org/professionals/KDOQI/guidelines_anemiaUP/index.htm. Accessed June 30, 2010
  • Sekkarie MA, Moss AH. Withholding and withdrawing dialysis: the role of physician specialty and education and patient functional status. Am J Kidney Dis 1998;31:464-472
  • Smith C, Da Silva-Gene M, Chandna S, et al. Choosing not to dialyze: Evaluation of planned non-dialytic management in a cohort of patients with end-stage renal disease. Nephron Clin Pract 2003;95:c40-c46
  • Murtagh FE, Marsh JE, Donohue P, et al. Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5. Nephrol Dial Transplant 2007;22:1955-1962
  • Smith DH, Guillion CM, Nichols G, et al. Cost of medical care for chronic kidney disease and comorbidity among enrollees in a large HMO population. J Am Soc Nephrol 2004;15:1300-1306
  • Lefebvre P, Duh MS, Buteau S, et al. Medical costs of untreated anemia in elderly patients with pre-dialysis chronic disease. J Am Soc Nephrol 2006;17:3497-3502
  • Nissenson AR, Wade S, Goodnough T, et al. Economic burden of anemia in an insured population. J Manag Care Pharm 2005;11:565-574
  • London R, Solis A, Goldberg GA, et al. Health care resource utilization and the impact of anemia management in patients with chronic kidney disease. Am J Kidney Dis 2002;40:539-548
  • Robbins JD, Kim JJ, Zdon G, et al. Resource use and patient care associated with chronic kidney disease in a manage care setting. J Manag Care Pharm 2003;9:238-247
  • Astor BC, Eustace JA, Powe NR, et al. Timing of nephrologist referral and arteriovenous access use: the CHOICE Study. Am J Kidney Dis 2001;38:494-501
  • Winkelmayer WC, Owen WF Jr, Levin R, et al. A propensity analysis of late versus early nephrologist referral and mortality on dialysis. J Am Soc Nephrol 2003;14:486-492
  • Patwardhan MB, Samsa GP, Matchar DB, et al. Advanced chronic kidney disease practice patterns among nephrologists and non-nephrologists: a database analysis. Clin J Am Soc Nephrol 2007;2:277-283
  • Curtis BM, Barrett BJ, Djurdjev O, et al. Evaluation and treatment of CKD patients before and at their first nephrologist encounter in Canada. Am J Kidney Dis 2007;50:733-742
  • Philipneri MD, Rocca Rey LA, Schnitzler MA, et al. Delivery patterns of recommended chronic kidney disease care in clinical practice: administrative claims-based analysis and systematic literature review. Clin Exp Nephrol 2008;12:41-52
  • Charles RF, Powe NR, Jaar BG, et al. Clinical testing patterns and cost implications of variation in the evaluation of CKD among US physicians. Am J Kidney Dis 2009;54:227-237
  • Levin A. Consequences of late referral on patient outcomes. Nephrol Dial Transplant 2000;15(Suppl 3):8-13
  • Ershler WB, Chen K, Reyes EB, et al. Economic burden of patients with anemia in selected diseases. Value Health 2005;8:629-638
  • Jungers P, Choukroun G, Robino C, et al. Epidemiology of end-stage renal disease in the Ile-de-France area: a prospective study in 1998. Nephrol Dial Transplant 2000;15:2000-2006
  • Jungers P, Choukrun G, Oualim Z, et al. Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in pre-dialysis patients. Nephrol Dial Transplant 2001;16:307-312
  • Gouva C, Nikolopoulos P, Ioannidis JPA, et al. Treating anemia early in renal failure patients slows decline of renal function: a randomized controlled trial. Kidney Int 2004;66:753-760
  • Keith DS, Nichols GA, Gullion CM, et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004;164:659-663
  • Mohanram A, Zhang Z, Shahinfar S, et al. Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy. Kidney Int 2004;66:1131-1138
  • Dean BB, Dylan M, Gano A Jr, et al. Erythropoiesis-stimulating protein therapy and the decline of renal function: a retrospective analysis of patients with chronic kidney disease. Curr Med Res Opin 2005;21:981-987
  • Go AS, Yang J, Ackerson LM, et al. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. Circulation 2006;113:2713-2723

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.